Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Passera

Showing results (101-110 of 161) with videos related to

Pageof 17
Sort By:
European Urology|August 31, 2016
Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate CancerFrancesco Porpiglia, Matteo Manfredi, Fabrizio Mele, et al.
Open Medicine (Warsaw, Poland)|March 30, 2017
Use of a simplified consent form to facilitate patient understanding of informed consent for laparoscopic cholecystectomyAlessandro Borello, Alessia Ferrarese, Roberto Passera, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 18, 2019
Risk of Gleason Score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly reduced by targeted versus standard biopsyStefano De Luca, Cristian Fiori, Enrico Bollito, et al.
Annals of Hematology|February 11, 2010
A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugsElena Crisà, Ermanno Venturino, Roberto Passera, et al.
Analytical and Quantitative Cytology and Histology|May 23, 2012
Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer: a validation study on an Italian patient population undergoing first and repeat biopsyEnrico Bollito, Stefano De Luca, Matteo Cicilano, et al.
Plos One|September 26, 2014
Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survivalCorrado Tarella, Angela Gueli, Federica Delaini, et al.
EJNMMI Research|October 16, 2020
[<sup>18</sup>F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trialGiulia Polverari, Francesco Ceci, Roberto Passera, et al.
Journal of Clinical Medicine|November 13, 2021
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced MelanomaVirginia Liberini, Marco Rubatto, Riccardo Mimmo, et al.
Cancers|May 9, 2020
<sup>18</sup>F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and SurvivalGiulia Polverari, Francesco Ceci, Valentina Bertaglia, et al.
The Journal of Urology|January 18, 2017
Multiparametric Magnetic Resonance/Ultrasound Fusion Prostate Biopsy: Number and Spatial Distribution of Cores for Better Index Tumor Detection and CharacterizationFrancesco Porpiglia, Stefano De Luca, Roberto Passera, et al.
Pageof 17

Showing results (101-110 of 161) with videos related to

Sort By:
Pageof 17
European Urology|August 31, 2016
Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate CancerFrancesco Porpiglia, Matteo Manfredi, Fabrizio Mele, et al.
Open Medicine (Warsaw, Poland)|March 30, 2017
Use of a simplified consent form to facilitate patient understanding of informed consent for laparoscopic cholecystectomyAlessandro Borello, Alessia Ferrarese, Roberto Passera, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|October 18, 2019
Risk of Gleason Score 3+4=7 prostate cancer upgrading at radical prostatectomy is significantly reduced by targeted versus standard biopsyStefano De Luca, Cristian Fiori, Enrico Bollito, et al.
Annals of Hematology|February 11, 2010
A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugsElena Crisà, Ermanno Venturino, Roberto Passera, et al.
Analytical and Quantitative Cytology and Histology|May 23, 2012
Prostate cancer gene 3 urine assay cutoff in diagnosis of prostate cancer: a validation study on an Italian patient population undergoing first and repeat biopsyEnrico Bollito, Stefano De Luca, Matteo Cicilano, et al.
Plos One|September 26, 2014
Rate of primary refractory disease in B and T-cell non-Hodgkin's lymphoma: correlation with long-term survivalCorrado Tarella, Angela Gueli, Federica Delaini, et al.
EJNMMI Research|October 16, 2020
[<sup>18</sup>F]FDG PET/CT for evaluating early response to neoadjuvant chemotherapy in pediatric patients with sarcoma: a prospective single-center trialGiulia Polverari, Francesco Ceci, Roberto Passera, et al.
Journal of Clinical Medicine|November 13, 2021
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced MelanomaVirginia Liberini, Marco Rubatto, Riccardo Mimmo, et al.
Cancers|May 9, 2020
<sup>18</sup>F-FDG Pet Parameters and Radiomics Features Analysis in Advanced Nsclc Treated with Immunotherapy as Predictors of Therapy Response and SurvivalGiulia Polverari, Francesco Ceci, Valentina Bertaglia, et al.
The Journal of Urology|January 18, 2017
Multiparametric Magnetic Resonance/Ultrasound Fusion Prostate Biopsy: Number and Spatial Distribution of Cores for Better Index Tumor Detection and CharacterizationFrancesco Porpiglia, Stefano De Luca, Roberto Passera, et al.
Pageof 17